KCNMA1 and HIV-1 infection: Thus, TRPML1 and BK channels might be targeted therapeutically to prevent re-activation of latent HIV-1 infection, and to decrease the prevalence and severity of HIV-1 associated neurocognitive disorders and other HIV-1 comorbidities.